Active Ingredient(s): Insulin Lispro
FDA Approved: * December 11, 2017
Pharm Company: * SANOFI-AVENTIS US
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Admelog Overview

Insulin lispro, sold under the brand name Humalog among others, is a type of manufactured insulin used to treat type I and type II diabetes.[2] Typically it is taken around the time of eating.[2] It is used by injection under the skin or within an insulin pump.[2][3] Onset of effects typically occurs within 30 minutes and lasts about 5 hours.[2] Often a longer acting insulin like NPH is also needed.[2&...

Read more Admelog Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Admelog Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Insulin Lispro
  • Injection: 100 Units/ml, 100unit/ml, 200units/ml
  • Solution: 1000 Units/10ml (100 Units/ml), 200 Units/ml, 300 Units/3ml (100 Units/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Admelog: (3 results)

Sorted by National Drug Code
  • 0024-5924 Admelog 100 U/Ml Intravenous; Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
  • 0024-5925 Admelog 100 U/Ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
  • 0024-5926 Admelog 100 U/Ml Intravenous; Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC

Other drugs which contain Insulin Lispro or a similar ingredient: (3 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA